262 related articles for article (PubMed ID: 12527049)
1. Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience.
Pirzkall A; Debus J; Haering P; Rhein B; Grosser KH; Höss A; Wannenmacher M
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):362-72. PubMed ID: 12527049
[TBL] [Abstract][Full Text] [Related]
2. High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas predominantly in the skull base location.
Jalali R; Loughrey C; Baumert B; Perks J; Warrington AP; Traish D; Ashley S; Brada M
Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):103-9. PubMed ID: 12069116
[TBL] [Abstract][Full Text] [Related]
3. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
Weber DC; Lomax AJ; Rutz HP; Stadelmann O; Egger E; Timmermann B; Pedroni ES; Verwey J; Miralbell R; Goitein G;
Radiother Oncol; 2004 Jun; 71(3):251-8. PubMed ID: 15172139
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution.
Milker-Zabel S; Zabel-du Bois A; Huber P; Schlegel W; Debus J
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):858-63. PubMed ID: 17379447
[TBL] [Abstract][Full Text] [Related]
5. Stereotactically guided conformal radiotherapy for meningiomas.
Alheit H; Saran FH; Warrington AP; Rosenberg I; Perks J; Jalali R; Shepherd S; Beardmore C; Baumert B; Brada M
Radiother Oncol; 1999 Feb; 50(2):145-50. PubMed ID: 10368037
[TBL] [Abstract][Full Text] [Related]
6. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
7. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results.
Debus J; Wuendrich M; Pirzkall A; Hoess A; Schlegel W; Zuna I; Engenhart-Cabillic R; Wannenmacher M
J Clin Oncol; 2001 Aug; 19(15):3547-53. PubMed ID: 11481362
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results.
Sajja R; Barnett GH; Lee SY; Harnisch G; Stevens GH; Lee J; Suh JH
Technol Cancer Res Treat; 2005 Dec; 4(6):675-82. PubMed ID: 16292888
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution.
Onodera S; Aoyama H; Katoh N; Taguchi H; Yasuda K; Yoshida D; Surtherland K; Suzuki R; Ishikawa M; Gerard B; Terasaka S; Shirato H
Jpn J Clin Oncol; 2011 Apr; 41(4):462-8. PubMed ID: 21177777
[TBL] [Abstract][Full Text] [Related]
10. Encouraging early clinical outcomes with helical tomotherapy-based image-guided intensity-modulated radiation therapy for residual, recurrent, and/or progressive benign/low-grade intracranial tumors: a comprehensive evaluation.
Gupta T; Wadasadawala T; Master Z; Phurailatpam R; Pai-Shetty R; Jalali R
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):756-64. PubMed ID: 21345610
[TBL] [Abstract][Full Text] [Related]
11. Optimization of stereotactic radiotherapy treatment delivery technique for base-of-skull meningiomas.
Clark BG; Candish C; Vollans E; Gete E; Lee R; Martin M; Ma R; McKenzie M
Med Dosim; 2008; 33(3):239-47. PubMed ID: 18674690
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiation therapy (IMRT) for meningioma.
Uy NW; Woo SY; Teh BS; Mai WY; Carpenter LS; Chiu JK; Lu HH; Gildenberg P; Trask T; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1265-70. PubMed ID: 12128128
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors.
Pirzkall A; Carol M; Lohr F; Höss A; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1371-80. PubMed ID: 11121636
[TBL] [Abstract][Full Text] [Related]
14. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.
Dawson LA; Anzai Y; Marsh L; Martel MK; Paulino A; Ship JA; Eisbruch A
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1117-26. PubMed ID: 10725621
[TBL] [Abstract][Full Text] [Related]
15. Skull base meningioma - comparison of intensity-modulated radiotherapy planning techniques using the moduleaf micro-multileaf collimator and helical tomotherapy.
Estall V; Fairfoul J; Jena R; Jefferies SJ; Burton KE; Burnet NG
Clin Oncol (R Coll Radiol); 2010 Apr; 22(3):179-84. PubMed ID: 20171061
[TBL] [Abstract][Full Text] [Related]
16. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
Wu Q; Manning M; Schmidt-Ullrich R; Mohan R
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):195-205. PubMed ID: 10656393
[TBL] [Abstract][Full Text] [Related]
17. Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature.
Milker-Zabel S; Zabel-du Bois A; Huber P; Schlegel W; Debus J
Strahlenther Onkol; 2006 Nov; 182(11):635-40. PubMed ID: 17072520
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
[TBL] [Abstract][Full Text] [Related]
19. Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT).
Combs SE; Adeberg S; Dittmar JO; Welzel T; Rieken S; Habermehl D; Huber PE; Debus J
Radiother Oncol; 2013 Feb; 106(2):186-91. PubMed ID: 22906549
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
